FIELD: pharmaceutics.
SUBSTANCE: invention relates to pharmaceutics. Described is use of calcium lactate for restoration of intestinal microbiocenosis in case of dysbiosis in an effective therapeutic daily dose of 0.5-1.5 g for an adult.
EFFECT: invention provides fast normalisation of composition and amount of intestinal microflora in case of dysbiosis.
1 cl, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBACTERIAL AGENTS AND METHOD FOR TREATING INTESTINAL YERSINIOSIS OR PSEUDOTUBERCULOSIS, OR COLIBACILLOSIS | 2016 |
|
RU2614730C1 |
| METHOD OF STUDY OF GASTRIC AND INTESTINAL MICROBIOTA DURING SUPPRESSION OF COLONIZATION RESISTANCE OF GASTRIC MUCOSA OF EXPERIMENTAL ANIMALS | 2019 |
|
RU2745654C1 |
| METHOD FOR ESTIMATING BIFIDUS BACTERIA AND LACTIC ACID BACILLI SURVIVAL IN EXPERIMENTAL ANIMAL'S GASTROINTESTINAL TRACT | 2012 |
|
RU2528867C2 |
| METHOD FOR SIMULATING INTESTINAL DYSBACTERIOSIS IN LABORATORY ANIMALS | 2011 |
|
RU2477894C1 |
| METHOD TO ASSESS EFFECT OF EXOGENOUS FACTORS AT INTESTINAL MICROFLORA IN CASE OF ITS DYSBIOTIC DISTURBANCES | 2012 |
|
RU2483113C1 |
| METHOD FOR ERADICATION OF HELICOBACTER PYLORI BACTERIA IN EXPERIMENTAL HELICOBACTERIOSIS IN CONVENTIONAL WHITE MICE AND A MEANS FOR ITS IMPLEMENTATION | 2020 |
|
RU2746590C1 |
| ANTI-HELICOBACTER AGENT AND METHOD FOR USE THEREOF | 2018 |
|
RU2713154C1 |
| APPLICATION OF PEPTIDE Thr-Lys-Pro-Arg-Pro-Gly-Pro (SELANG) FOR DYSBIOSIS CORRECTION UNDER CHRONIC IMMOBILIZATION STRESS | 2018 |
|
RU2681217C1 |
| USE OF PEPTIDE Met-Glu-His-Phe-Pro-Gly-Pro (Semax) FOR DYSBIOSIS CORRECTION IN CHRONIC IMMOBILIZATION STRESS | 2019 |
|
RU2709527C1 |
| METHOD FOR PREVENTION OF DEVELOPING BACTERIAL INTESTINAL INFECTION | 2012 |
|
RU2526806C2 |
